| Andrew Walid Mezher, MD | |
|
981045 Nebraska Medical Ctr, Omaha, NE 68198-4496 | |
| (402) 559-1018 | |
| Not Available |
| Full Name | Andrew Walid Mezher |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 981045 Nebraska Medical Ctr, Omaha, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578192365 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 64572 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Walid Mezher, MD 3019 Decatur Street, Omaha, NE 68111 Ph: (818) 442-4992 | Andrew Walid Mezher, MD 981045 Nebraska Medical Ctr, Omaha, NE 68198-4496 Ph: (402) 559-1018 |
News Archive
Genes make proteins and proteins tell your body's cells what to do: one talks to the next, which talks to the next, and to the next. Like a game of telephone, researchers call these "signaling pathways". Abnormalities in these signaling pathways can cause the growth and survival of cancer cells. Commonly, mutations or rearrangements of genes in the MAPK signaling pathway create cancer's fast growth, and alterations in the PI3K signaling pathway allow cancer cells to survive into virtual immortality.
Dr. Keith Corl was working in a Las Vegas emergency room when a patient arrived with chest pain. The patient, wearing his street clothes, had a two-minute exam in the triage area with a doctor, who ordered an X-ray and several other tests.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim's new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC in patients whose tumors have certain EGFR gene mutations.
The American Health Assistance Foundation, a nonprofit organization with a history of funding breakthrough research on age-related vision diseases, announced today that it has awarded 21 new grants totaling $2.1 million to scientists worldwide who are studying glaucoma and macular degeneration. The two conditions are the leading causes of irreversible blindness in the world.
› Verified 1 days ago
Dr. Daniel J Gross, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1501 Jackson St Ste 100, Omaha, NE 68102 Phone: 402-999-2329 Fax: 402-915-0095 | |
Dr. Vijay Kumar Agarwal, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 727 N 120th St, Omaha, NE 68154 Phone: 402-493-2100 Fax: 402-493-2104 | |
Mr. Joseph Kennedy Costello Iv, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 224 N. 49th St. #4a, Omaha, NE 68132 Phone: 402-659-4247 | |
Arthur Weaver, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 5310 S 84th St, Omaha, NE 68127 Phone: 402-827-6510 | |
Dr. Louise Winter, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 14104 S St, Omaha, NE 68137 Phone: 402-827-6710 | |
Dr. James Bane, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 11106 N 61st St, Omaha, NE 68152 Phone: 402-573-9398 |